| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
49,160,000 |
| Market
Cap: |
351.99(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.14 - $13.81 |
|
| Level
I Sector: |
Financials |
| Level
II Sector: |
Financial Services |
| Level
III Sector: |
Diversified Investments |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Co.'s primary product candidate, pemvidutide (proposed INN), is a good laboratory practices-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and non-alcoholic steatohepatitis. In addition, Co. is developing HepTcell, an immunotherapeutic agent designed to achieve a functional cure for chronic hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
300 |
31,500 |
| Total Buy Value |
$0 |
$0 |
$863 |
$138,033 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
1 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
155,302 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,133,902 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
9 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Runge Jeffrey W. |
Director |
– • – |
2017-01-20 |
4 |
OE |
$3.11 |
$62,200 |
D/D |
20,000 |
197,700 |
|
- |
|
| Schaffer Derace L |
Director |
– • – |
2017-01-13 |
4 |
OE |
$2.20 |
$44,000 |
D/D |
20,000 |
1,043,782 |
|
- |
|
| St Peter Steven |
Director |
– • – |
2017-01-04 |
4 |
OE |
$2.20 |
$181,500 |
D/D |
70,000 |
205,004 |
|
- |
|
| Macneill Philip |
VP, CFO, Treasurer, Secretary |
• – – |
2016-12-21 |
4 |
OE |
$1.66 |
$37,861 |
D/D |
22,657 |
126,346 |
|
- |
|
| Frohlich Phil |
10% Owner |
– – • |
2016-12-09 |
4 |
S |
$3.26 |
$1,422,416 |
I/I |
(436,324) |
6,626,403 |
|
- |
|
| Frohlich Phil |
10% Owner |
– – • |
2016-12-08 |
4 |
S |
$3.25 |
$1,431,557 |
I/I |
(440,479) |
7,062,727 |
|
- |
|
| Frohlich Phil |
10% Owner |
– – • |
2016-12-07 |
4 |
S |
$3.26 |
$1,557,723 |
I/I |
(477,829) |
7,503,206 |
|
- |
|
| Runge Jeffrey W. |
Director |
– • – |
2016-11-28 |
4 |
OE |
$2.20 |
$44,000 |
D/D |
20,000 |
177,700 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-11-22 |
4 |
OE |
$1.19 |
$895,213 |
D/D |
483,733 |
898,055 |
|
- |
|
| Gill John |
President and CEO |
• • – |
2016-11-22 |
4 |
OE |
$2.20 |
$220,000 |
D/D |
100,000 |
822,244 |
|
- |
|
| Sayare Mitchel |
Director |
– • – |
2016-11-22 |
4 |
OE |
$1.45 |
$564,845 |
D/D |
270,500 |
275,500 |
|
- |
|
| Schaffer Derace L |
Director |
– • – |
2016-09-30 |
4 |
OE |
$1.45 |
$233,100 |
D/D |
130,000 |
1,023,782 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-09-28 |
4 |
OE |
$1.19 |
$343,625 |
D/D |
237,500 |
414,322 |
|
- |
|
| Macneill Philip |
VP, CFO, Treasurer, Secretary |
• – – |
2016-09-20 |
4 |
OE |
$1.13 |
$87,725 |
D/D |
53,689 |
103,689 |
|
- |
|
| St Peter Steven |
Director |
– • – |
2016-09-16 |
4 |
OE |
$1.45 |
$175,907 |
D/D |
110,004 |
135,004 |
|
- |
|
| Gill John |
President and CEO |
• • – |
2016-09-16 |
4 |
OE |
$2.47 |
$75,300 |
D/D |
30,000 |
722,244 |
|
- |
|
| Runge Jeffrey W. |
Director |
– • – |
2016-09-15 |
4 |
OE |
$1.35 |
$184,800 |
D/D |
120,000 |
157,700 |
|
- |
|
| Gill John |
President and CEO |
• • – |
2016-09-15 |
4 |
OE |
$1.45 |
$124,000 |
D/D |
80,000 |
692,244 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-04-13 |
4 |
AS |
$2.20 |
$724,579 |
D/D |
(329,354) |
176,822 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-04-13 |
4 |
OE |
$1.16 |
$392,240 |
D/D |
329,354 |
251,822 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-04-08 |
4 |
AS |
$2.20 |
$14,080 |
D/D |
(6,400) |
176,822 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-04-08 |
4 |
OE |
$1.76 |
$11,264 |
D/D |
6,400 |
183,222 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-04-07 |
4 |
AS |
$2.20 |
$11,807 |
D/D |
(5,367) |
176,822 |
|
- |
|
| Richman Eric I |
Director |
– • – |
2016-04-07 |
4 |
OE |
$1.76 |
$9,446 |
D/D |
5,367 |
182,189 |
|
- |
|
| Macneill Philip |
VP, CFO, Treasurer, Secretary |
• – – |
2015-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
|
- |
|
417 Records found
|
|
Page 10 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.11 (1.51%) 
